These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
388 related items for PubMed ID: 15482538
1. Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma. Takuma Y, Nouso K, Kobayashi Y, Nakamura S, Tanaka H, Matsumoto E, Fujikawa T, Suzuki M, Hanafusa T, Shiratori Y. J Gastroenterol Hepatol; 2004 Nov; 19(11):1300-4. PubMed ID: 15482538 [Abstract] [Full Text] [Related]
2. Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis. Satra M, Gatselis N, Iliopoulos D, Zacharoulis D, Dalekos GN, Tsezou A. J Viral Hepat; 2007 Jan; 14(1):41-7. PubMed ID: 17212643 [Abstract] [Full Text] [Related]
3. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression. Chen CJ, Tsai NM, Liu YC, Ho LI, Hsieh HF, Yen CY, Harn HJ. Eur J Surg Oncol; 2002 Apr; 28(3):225-34. PubMed ID: 11944954 [Abstract] [Full Text] [Related]
4. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status. Saini N, Srinivasan R, Chawla Y, Sharma S, Chakraborti A, Rajwanshi A. Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485 [Abstract] [Full Text] [Related]
5. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma. Miura N, Maeda Y, Kanbe T, Yazama H, Takeda Y, Sato R, Tsukamoto T, Sato E, Marumoto A, Harada T, Sano A, Kishimoto Y, Hirooka Y, Murawaki Y, Hasegawa J, Shiota G. Clin Cancer Res; 2005 May 01; 11(9):3205-9. PubMed ID: 15867214 [Abstract] [Full Text] [Related]
6. Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma. Toshikuni N, Nouso K, Higashi T, Nakatsukasa H, Onishi T, Kaneyoshi T, Kobayashi Y, Kariyama K, Yamamoto K, Tsuji T. Br J Cancer; 2000 Feb 01; 82(4):833-7. PubMed ID: 10732755 [Abstract] [Full Text] [Related]
8. Methylation-related silencing of p14ARF gene correlates with telomerase activity and mRNA expression of human telomerase reverse transcriptase in hepatocellular carcinoma. Zhang C, Guo X, Zhang L, Lu Z, Ma N, Cheng Y, Shen F, Zhang B, Wu M, Wei L. J Surg Oncol; 2008 Nov 01; 98(6):462-8. PubMed ID: 18683194 [Abstract] [Full Text] [Related]
9. Telomerase activity and expression of human telomerase catalytic subunit gene in esophageal tissues. Tominaga T, Kashimura H, Suzuki K, Nakahara A, Tanaka N, Noguchi M, Itabashi M, Ohkawa J. J Gastroenterol; 2002 Nov 01; 37(6):418-27. PubMed ID: 12108675 [Abstract] [Full Text] [Related]
10. Telomerase and c-myc expression in hepatocellular carcinomas. Liu YC, Chen CJ, Wu HS, Chan DC, Yu JC, Yang AH, Cheng YL, Lee SC, Harn HJ. Eur J Surg Oncol; 2004 May 01; 30(4):384-90. PubMed ID: 15063891 [Abstract] [Full Text] [Related]
11. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer. Takihana Y, Tsuchida T, Fukasawa M, Araki I, Tanabe N, Takeda M. Int J Urol; 2006 Apr 01; 13(4):401-8. PubMed ID: 16734859 [Abstract] [Full Text] [Related]
12. Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer. Ohuchida K, Mizumoto K, Ogura Y, Ishikawa N, Nagai E, Yamaguchi K, Tanaka M. Clin Cancer Res; 2005 Mar 15; 11(6):2285-92. PubMed ID: 15788678 [Abstract] [Full Text] [Related]
13. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer. Metzger R, Vallbohmer D, Müller-Tidow C, Higashi H, Bollschweiler E, Warnecke-Eberz U, Brabender J, Baldus SE, Xi H, Berdel WE, Serve H, Hoelscher AH, Schneider PM. Anticancer Res; 2009 Apr 15; 29(4):1157-62. PubMed ID: 19414359 [Abstract] [Full Text] [Related]
14. Abnormal expression of hepatomas and circulating telomerase and its clinical values. Wu W, Yao DF, Qiu LW, Wu XH, Yao M, Su XQ, Zou L. Hepatobiliary Pancreat Dis Int; 2005 Nov 15; 4(4):544-9. PubMed ID: 16286259 [Abstract] [Full Text] [Related]
16. Quantitative assessment of hTERT mRNA expression in dysplastic nodules of HBV-related hepatocarcinogenesis. Oh BK, Kim YJ, Park YN, Choi J, Kim KS, Park C. Am J Gastroenterol; 2006 Apr 15; 101(4):831-8. PubMed ID: 16494581 [Abstract] [Full Text] [Related]
17. Telomerase activity and telomerase catalytic subunit in hepatocellular carcinoma. Lee CM, Hsu CY, Eng HL, Huang WS, Lu SN, Changchien CS, Chen CL, Cho CL. Hepatogastroenterology; 2004 Apr 15; 51(57):796-800. PubMed ID: 15143919 [Abstract] [Full Text] [Related]
18. Demonstration of human telomerase reverse transcriptase in human colorectal carcinomas by in situ hybridization. Kammori M, Kanauchi H, Nakamura K, Kawahara M, Weber TK, Mafune K, Kaminishi M, Takubo K. Int J Oncol; 2002 Jan 15; 20(1):15-21. PubMed ID: 11743637 [Abstract] [Full Text] [Related]
19. Immuno-histochemical detection of human telomerase reverse transcriptase in human liver tissues. Kawakami Y, Kitamoto M, Nakanishi T, Yasui W, Tahara E, Nakayama J, Ishikawa F, Tahara H, Ide T, Kajiyama G. Oncogene; 2000 Aug 10; 19(34):3888-93. PubMed ID: 10951582 [Abstract] [Full Text] [Related]
20. Telomerase activity and expression of telomerase genes in squamous dysplasia and squamous cell carcinoma of the esophagus. Yu HP, Xu SQ, Lu WH, Li YY, Li F, Wang XL, Su YH. J Surg Oncol; 2004 May 01; 86(2):99-104. PubMed ID: 15112252 [Abstract] [Full Text] [Related] Page: [Next] [New Search]